'Indian pharma grapples with quality culture'

As global regulatory scrutiny intensifies, pharmaceutical companies are facing increasing pressure to not only meet compliance standards but to embed a robust quality culture into their very core operations.

- Peethaambaran, Chennai

Fostering such a culture is no longer a mere option but a critical imperative for sustainable growth, according to Dr. Tom Thomas Puthiyaparampil, country head, Syner-G Biopharma Group.

Asserting that 'without a strong quality culture, no industry can sustain today', he said this heightened-focus necessitates that pharmaceutical industries should proactively adopt multifaceted strategies to build and maintain the foundational quality culture essential for thriving in today's complex regulatory landscape. He made these remarks while delivering a keynote speech on 'Development of Sustainable Quality Culture in Pharma Industry' at an industry conference held last week in Chennai as part of the pharmaceutical exhibition, Pharmac South.